#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neurodevelopmental disorder Soft tissue necrosis Primary hyperoxaluria Ischaemic stroke Familial hypertriglyceridaemia Skin cancer Retinal artery occlusion Usher's syndrome Anti-myelin-associated glycoprotein antibodies positive Non-small cell lung cancer Lupus nephritis Small cell lung cancer extensive stage Marginal zone lymphoma recurrent Thrombotic thrombocytopenic purpura Exudative retinopathy More trials…

    Learn about Rare Diseases

    Acute respiratory distress syndrome – Life with Disease Acute respiratory distress syndrome – Diagnostics Glycogen storage disease type II – Treatment Vascular malformation – Diagnostics Pemphigoid – Treatment Systemic mastocytosis – Trials in Disease Urea cycle disorder Cystic fibrosis Medulloblastoma – Treatment Fragile X syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gskvx000000009151 Rebisufligene Etisparvovec Siplizumab Ide397 Pegfilgrastim Savolitinib Volixibat Levoleucovorin Pimavanserin Tartrate CIRTUVIVINT Imipenem Docetaxel Neomycin Sulfate Anhydrous Benzoyl Peroxide Daplusiran Ivermectin Masofaniten Lifileucel GRNA-001 Romidepsin More therapies…

    Learn about Your Condition

    Pulmonary vascular disorder Lung cancer metastatic Neuralgia Papillary thyroid cancer Conjunctivitis Biliary tract disorder Cervix carcinoma Juvenile spondyloarthritis Varicella Herpes virus infection Acute coronary syndrome Meningorrhagia Heart disease congenital Intracranial aneurysm Breast cancer female More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cervix carcinoma recurrent

  • Study of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Lung adenocarcinoma
    • Cholangiocarcinoma
    • Breast cancer
    Investigated Drugs:
    • Bemarituzumab
    Austria Belgium Bulgaria Czechia Denmark Finland +9

  • Study on the Safety and Effectiveness of IMGN151 for Women with Recurrent Endometrial and Ovarian Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Cervix carcinoma recurrent
    • Endometrial cancer recurrent
    • Fallopian tube cancer
    Investigated Drugs:
    • Brimonidine Tartrate
    • Imgn151
    • Prednisolone Acetate
    Belgium France Germany Ireland Italy The Netherlands +1

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!